Caladan Bio specializes in advanced bioreactor technology, offering next-generation benchtop systems that are designed for high throughput and full automation. Their flagship product, the Caladan System, features novel hardware that enhances both throughput and data acquisition capabilities for each experiment. This system is complemented by fully integrated software that allows users to design experiments, monitor them in real-time, and analyze data all within a single platform. The hardware is modular and user-friendly, incorporating a complete suite of sensors and systems for comprehensive monitoring and control, as well as options for both single-use and reusable tanks.

The software component of Caladan Bio's technology emphasizes streamlined experimentation through real-time monitoring and high-density data analysis. It includes a no-code interface that enables users to create complex experiment designs with time- and event-based triggers, facilitating advanced experimental setups. The live experiment view provides immediate feedback through real-time data visualization, while integrated data analytics help close the loop on experiments, driving further design iterations and enhancing overall research efficiency. This combination of innovative hardware and sophisticated software positions Caladan Bio as a leader in the bioprocessing field.

United States

Caladan Bio is a Brooklyn-based startup specializing in next-generation bioreactors, offering modular, affordable, and cutting-edge solutions. The company's first product, the Caladan 250, is a high throughput benchtop bioreactor system that leverages AI and machine learning to enable advanced data capture and increase throughput. Caladan Bio is focused on revolutionizing the way biotechnology research is conducted by creating lower-cost, cutting-edge bioreactors and advanced software.

Caladan Bio

Company Details